Brand name: Spravato TM
Active ingredients: esketamine
What it is used for
SPRAVATO is indicated for treatment resistant depression (Major Depressive Disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current moderate to severe depressive episode).,SPRAVATO is to be initiated in conjunction with a newly initiated oral antidepressant.
How to take it
The way to take this medicine is: Nasal. This medicine is given through the nose and absorbed through the nasal passages.
- Store below 25 degrees Celsius
- Shelf lifetime is 48 Months.
- Store below 25 degrees Celsius
- Shelf lifetime is 48 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear colourless to slightly yellowish aqueous solution packaged in Type 1 glass vial, rubber stopper and assemble inside a single use nasal spray device
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is
Pregnant or planning a pregnancy?
For the active ingredient esketamine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
